TransThera Announces the Global Multicenter Phase 3 Clinical Trial Completed First Patient Dosing in the US Evaluating Tinengotinib in FGFRi Relapsed/Refractory Patients with Cholangiocarcinoma December 21, 2023 β 21:45
CellOrigin announced treatment of the first patient with CAR-M in China and reported the second generation of CAR-M for solid tumors December 21, 2023 β 01:00
Consumer TikTok’s Strategic Compromise: Navigating Local Protectionism with $1.5 Billion Tokopedia Deal for Indonesian Market Re-entry December 21, 2023 β 00:25
